Abstract
Experiments have been undertaken to further characterize the actions of the synthetic immunoadjuvant compound, muramyl dipeptide (MDP), in an animal model simulating surgical infection. When used prophylactically in combination with antibiotics, MDP proved to be significantly additive in terms of local and systemic effects, and survival, to both chloramphenicol (p less than 0.01) and cephaloridine (p less than 0.05). The combined use of MDP and cephaloridine therapy, initiated four or six hours following infectious challenge and including a surgical foreign body in starved and refed animals, showed statistically significant decreases in bacteremia during early time periods, as well an increased early survival (p less than 0.02), compared with the use of cephaloridine alone. Benefits observed in the therapeutic mode were of lesser magnitude than those observed following prophylactic use, but the model used was a much more significant physiologic challenge. Evidence indicating additive effects to those of antibiotics is essential prior to the use of MDP in clinical trials.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Calhoun K., Trachtenberg L., Hart K., Polk H. C., Jr Corynebacterium parvum: immunomodulation in local bacterial infections. Surgery. 1980 Jan;87(1):52–58. [PubMed] [Google Scholar]
- Chedid L., Audibert F., Johnson A. G. Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents. Prog Allergy. 1978;25:63–105. [PubMed] [Google Scholar]
- Chedid L., Parant M., Parant F., Lefrancher P., Choay J., Lederer E. Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs. Proc Natl Acad Sci U S A. 1977 May;74(5):2089–2093. doi: 10.1073/pnas.74.5.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FREUND J. The mode of action of immunologic adjuvants. Bibl Tuberc. 1956;(10):130–148. [PubMed] [Google Scholar]
- Fagelman K. M., Flint L. M., Jr, McCoy M. T., Polk H. C., Jr, Trachtenberg L. S. Simulated surgical wound infection in mice: effect of stimulation on nonspecific host defense mechanisms. Arch Surg. 1981 Jun;116(6):761–764. doi: 10.1001/archsurg.1981.01380180021005. [DOI] [PubMed] [Google Scholar]
- Galland R. B., Trachtenberg L. S., Rynerson N., Polk H. C., Jr Nonspecific enhancement of resistance to local bacterial infection in starved mice. Arch Surg. 1982 Feb;117(2):161–164. doi: 10.1001/archsurg.1982.01380260041007. [DOI] [PubMed] [Google Scholar]
- Parant M., Parant F., Chedid L. Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3395–3399. doi: 10.1073/pnas.75.7.3395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Polk H. C., Jr, Calhoun J. H., Lowrey L. D., Blanchard S. P., Brewer R. J., Adams S. T., Chedid L. Nonspecific enhancement of host defenses against infection: experimental evidence of a new order of efficacy and safety. Surgery. 1981 Aug;90(2):376–380. [PubMed] [Google Scholar]
- Rouben D. P., Fagelman K., McCoy M. T., Polk H. C., Jr Enhancement of nonspecific host defenses against local bacterial challenge. Surg Forum. 1977;28:44–45. [PubMed] [Google Scholar]
- Tanaka A., Nagao S., Nagao R., Kotani S., Shiba T., Kusumoto S. Stimulation of the reticuloendothelial system of mice by muramyl dipeptide. Infect Immun. 1979 May;24(2):302–307. doi: 10.1128/iai.24.2.302-307.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]